Company:  ELOXX PHARMACEUTICALS, IN ... (ELOX)
Form Type:  SC 13G/A
Filing Date:  2/11/2019 
CIK:  0001035354 
Address:  950 WINTER STREET 
City, State, Zip:  WALTHAM, Massachusetts 02451 
Telephone:  (858) 909-0749 
Fiscal Year:  06/30 
Last Trade
Last Trade: 
$13.34  
Change: 
0.46 (3.57%)  
Trade Time: 
03:22 PM EST  
Market Cap: 
$468.57M
Trade ELOX now with 

© 2019  
Description of Business
On December 19, 2017, the Sevion Therapeutics, Inc. ("Sevion") acquired Eloxx Pharmaceuticals, Limited ("Private Eloxx") pursuant to a merger between the companies (the "Transaction"). Upon consummation of the Transaction (the "Closing"), Sevion adopted the business plan of Private Eloxx and discontinued the pursuit of Sevion's business plan pre-Closing. In connection with the Transaction, Sevion agreed to acquire all of the outstanding capital stock of Private Eloxx in exchange for the issuance of an aggregate 20,316,656 shares of the Sevion's common stock, par value $0.01 per share (the "Common Stock"), after giving effect to a 1-for-20 reverse split effected immediately prior to the Transaction. As a result of the Transaction, Private Eloxx became a wholly-owned subsidiary of Sevion. While Sevion was the legal acquirer in the transaction, Private Eloxx was deemed the accounting acquirer.
Register and access this filing in:     
  FORM SC 13G/A